Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brefel-Courbon

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Revue Neurologique|November 26, 2013
[A therapeutic educational program in Parkinson's disease: ETPARK]F Ory Magne, C Arcari, C Canivet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 16, 1999
[Reduction of the pressor effect of fluoxetine after V1A-vasopressin receptor blockade in the conscious rats]E Lazartigues, S Costes, C Brefel-Courbon, et al.
Acta Neurologica Scandinavica|August 24, 2017
Cognitive complaint in early Parkinson's disease: A pilot studyJ Dupouy, F Ory-Magne, C Mekies, et al.
Headache|March 17, 2001
Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot studyS Descombes, C Brefel-Courbon, C Thalamas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 17, 2007
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex studyA Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, et al.
Clinical Neuropharmacology|October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollisC Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.
Clinical Neuropharmacology|June 8, 2001
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic studyJ L Montastruc, C Brefel-Courbon, J M Senard, et al.
Revue Neurologique|October 8, 2014
An individual rehabilitation program: evaluation by Parkinsonian patients and their physiotherapistsF Ory Magne, N Fabre, C Gu, et al.
Fundamental & Clinical Pharmacology|December 29, 2000
Fluoxetine-induced pressor response in freely moving rats: a role for vasopressin and sympathetic toneE Lazartigues, C Brefel-Courbon, H Bagheri, et al.
Fundamental & Clinical Pharmacology|August 26, 1998
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot studyJ L Montastruc, M Pelat, P Verwaerde, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Revue Neurologique|November 26, 2013
[A therapeutic educational program in Parkinson's disease: ETPARK]F Ory Magne, C Arcari, C Canivet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 16, 1999
[Reduction of the pressor effect of fluoxetine after V1A-vasopressin receptor blockade in the conscious rats]E Lazartigues, S Costes, C Brefel-Courbon, et al.
Acta Neurologica Scandinavica|August 24, 2017
Cognitive complaint in early Parkinson's disease: A pilot studyJ Dupouy, F Ory-Magne, C Mekies, et al.
Headache|March 17, 2001
Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot studyS Descombes, C Brefel-Courbon, C Thalamas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 17, 2007
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex studyA Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, et al.
Clinical Neuropharmacology|October 6, 2000
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollisC Brefel-Courbon, M Simonetta-Moreau, C Moré, et al.
Clinical Neuropharmacology|June 8, 2001
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic studyJ L Montastruc, C Brefel-Courbon, J M Senard, et al.
Revue Neurologique|October 8, 2014
An individual rehabilitation program: evaluation by Parkinsonian patients and their physiotherapistsF Ory Magne, N Fabre, C Gu, et al.
Fundamental & Clinical Pharmacology|December 29, 2000
Fluoxetine-induced pressor response in freely moving rats: a role for vasopressin and sympathetic toneE Lazartigues, C Brefel-Courbon, H Bagheri, et al.
Fundamental & Clinical Pharmacology|August 26, 1998
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot studyJ L Montastruc, M Pelat, P Verwaerde, et al.
Pageof 5